Phage Therapy: A Precision Strike Against Diabetic Foot Osteomyelitis #ActAgainstAmputation

Exciting new data from our friend and colleague Ben Lipsky and his team highlights a potential shift in how we approach one of our most stubborn challenges: Staphylococcus aureus (StA) in diabetic foot osteomyelitis (DFO). Current standards of care for DFO are often unsatisfactory. This Phase 2, randomized, double-blind, placebo-controlled trial investigated BX211, a personalized... Continue Reading →

@FebrilePodcast focuses State of the Art (StAR) on limb preservation with @USC Professors DG Armstrong, @TzeWoeiTan, @Emory Professor @LimbsandLungs and @UW_medicine Prof. Meghan Brennan #ActAgainstAmputation @IDSAInfo @USC_Vascular

https://player.captivate.fm/episode/46e6e398-323e-4acc-b272-a6c43efb1382 Episode 98 of the Febrile podcast 98: StAR: Diabetes-related Foot Infections Episode 98 โ€ข 22nd April 2024 โ€ข Febrile โ€ข Sara Dong Shownotes This StAR episode features the CID State-of-the-Art Review on evaluation and management of diabetes-related foot infections. Our guest stars this episode are: Dr. Meghan Brennan (ID physician at University of Wisconsin) Dr. Marcos Schechter (ID physician... Continue Reading →

Empirical Antibiotic Therapy in Diabetic Foot Ulcers: A Double-Edged Sword? #DiabeticFootUlcers #AntibioticTherapy #HospitalizationRates #ActAgainstAmputation @absteward #IDSA

In a landscape where clinicians are increasingly exploring novel approaches to diabetic foot ulcer management, a recent study led by Brian Schmidt from the University of Michiganโ€”co-authored by Rodica Pop-Busui, president of the American Diabetes Association, Keith Kaye, of the Robert Wood Johnson Medical School and Dr. David G. Armstrong, a leading podiatric surgeon and... Continue Reading →

Up ↑

Verified by MonsterInsights